Although there has been much discussion as to how the anaesthetist should divide his time between the operating theatre, wards, intensive care units, etc, less attention has been paid to the actual content of his work. An American description of the work of the anaesthesiologist lists a variety of duties involving the relief of pain in its broadest sense (American Board of Anaesthesiology 1966).He is sometimes affectionately referred to as the 'gas man' but perhaps the 'drug man' would be more appropriate. He has to acquire a very detailed knowledge of the mode of action and clinical application of a number of drugs, perhaps more detailed than in any other branch of medicine.
Clinicalpharmacology and anaesthesia
Clinical pharmacology deals with the action of drugs in man and can be looked on as the bridge between basic medical science and clinical practice. The anaesthetist is particularly fitted to be a good clinical pharmacologist for a number of reasons: by training and study; he sees drug actions (onset, peak effect, wearing off) and interactions more frequently than in any other branch of medicine; he is experienced in making observations; the discipline of record keeping is well developed; he has access to large numbers of patients. In addition, some anaesthetists find the routine clinical practice of anaesthesia boring and the assessment of drug actions brightens a dull, routine operating list.
. Clinical pharmacology falls into two broad categories: drug-patient relationship r improving patient treatment by using available knowledge; and patient-drug relationshipunderstanding how drugs work, how they affect patients and how patients respond to drugs. This paper looks at some aspects of clinical pharmacology of interest to anaesthetists. It must be appreciated that clinical research does not, of necessity, require expensive equipment. A properly motivated anaesthetist with lots of 'patients and patience' can make useful simple observations, often of a subjective nature, and contribute to achieving the motto of the Association of Anaesthetists of Great Britain and Ireland 'in somno securates'.
Clinical trials
The objective of clinical trials has been described by Gray (l967) as 'obtaining the maximum aJPount of unbiased information concerning the principal actions and side effects of drugs in the shortest possible time and with the minimum upset to the patient'. This still applies today when we aim to see what happens if a group of patients is given the treatment under study, a standard treatment, or no treatment, when ethically and practically permissable.
The aim of many current clinical trials is to find drugs which are less toxic than those currently available. One must first define the objectives of the clinical trial, write them down, plan a protocol, try it out, and amend if necessary, then finish up with a final protocol which can only be altered on ethical grounds. The problems involved vary from drug to drug and have been adequately documented. They include individual variation, suitable patients, avoidance of bias, double-blind technique and the role of placebo.
An example is the study of the efficacy of cyclizine and perphenazine as anti-emetics in the control of postoperative vomiting (Dundee et al. 1975) . Variables which were controlled in this study were: sex of patients (females of reproductive age); nature of operation (7-10 minute D & C); standard anaesthetic (methohexitone-Njo-Oj): surroundings and attendants (one hospital unit); observations (N and Y, 0-1, 1-6,0-6 hours postoperatively). The emetic stimulus was premedication with an opiate: pethidine 100 mg, or morphine 10 or 15 mg. Morphine causes a longer period of postoperative vomiting than pethidine. These opiates were given alone and combined with cyclizine 50 mg, or perphenazine 5 mg and 2.5 mg, each to groups of not less than 50 patients (1400 subjects in full study). The two doses of perphenazine were given because of disagreement in the published literature as to which is better.
This study showed a marked reduction in postoperative nausea and vomiting in all groups of patients given an anti-emetic, as compared with the series given the same opiate alone. The study also showed that: cyclizine 50 mg and perphenazine 5 mg are approximately equipotent as anti-emetics; perphenazine 5 mg is more effective than the 2.5 mg dose; both anti-emetics are less effective against sickness following 15 mg morphine than following 10 mg, i.e. both are of limited potency; anti-emetics are most effective in reducing emesis of short duration such as follows pethidine, and are rather short-acting; restlessness was not uncommon when 5 mg perphenazine was given. This complication was not seen with cyclizine 50 mg. On the' basis of this study 50 mg cyclizine is a safe and effective anti-emetic which will safely reduce the nausea and vomiting after opiates. It is preferred to perphenazine because of its lower toxicity.
Reliefof chronic pain
This a field in which the anaesthetist makes a major contribution as a clinical pharmacologist. His initial involvement probably resulted from his other ability to perform nerve blocks accompanied by his greater than average knowledge of the action of analgesics.
The measurement of pain in man is a problem which deserves serious consideration. Animal studies are of limited value; apart from detecting drugs with an analgesic action they do not allow this to be quantified and they are of no value in showing the effective duration of action of a compound. Furthermore, pain is a largely subjective sensation -what I feel, what hurts me -and as such can be affected by drugs other than analgesics. One can, however, quantify subjective feelings by the assigment of numerals (or other symbols) to represent certain states. The patient and a trained observer can best be used to quantify pain. Alternatively, a visual analogue can be used to quantify pain or pain relief. It is on the basis of such studies that new analgesics can be evaluated.
Failure of clinical application of pharmacological knowledge
While patients have undoubtedly benefited from our increasing understanding of the action of drugs, in the routine clinical practice of anaesthesia there are a number of incidents which could be avoided by a proper application of clinical pharmacological knowledge. These are not major complications but are of great importance to those involved, whether they be patients, anaesthetists, nurses or surgeons. Ambulant patients are particularly at risk from suxamethonium muscle pains, which can be very severe; these can easily and safely be prevented by prior treatment with small doses of non-depolarizing relaxants. Awareness during the early stages of anaesthesia is a particular problem in obstetrics, occurring in attempts to give a high oxygen concentration prior to the birth of the baby; this is completely preventable with careful attention to technique. A 10-12 day follow up will reveal a surprisingly high incidence of venous thrombosis, particularly with benzodiazepines. Many patients are routinely given unnecessary preoperative injections of atropine or hyoscine; the resulting unpleasant dryness of the mouth could beavoided, at no risk to the patient, by giving these intravenously at the induction when their use is specifically indicated.
The risks of atmospheric pollution on the health of all theatre staff are not definitely known, but there is suspicion as to their hazards; if this occurred in an industrial situation legislation would have made ducting or other means of removing the contaminants compulsory. Have we completely abandoned the closed circuit as a potential solution? Except in a few centres postoperative pain reliefis very inadequate, particularly in thoracic patients; this is a situation analagous to the pain of terminal malignancy, in which the failings are time, staffand patience and not the inavailability of effective drugs. This is not a full list of situations where available clinical pharmacological knowledge is not used fully in treatment of patients. Excessive preoperative anxiety, postoperative restlessness and pre-and postoperative vomiting can all be prevented by drugs which are available and fully investigated. Preventable incidents have followed the too-early discharge of outpatients after general anaesthesia or the inadequate instruction ofthe patient and attendants; we know enough of their pharmacokinetics to prevent this.
Conclusions
This paper describes a number of fields in which the clinical anaesthetist practices as a good clinical pharmacologist. He is well equipped for this task, but there are a number of examples where patient management does not make full use of our current knowledge of drugs.
